Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Cara Therapeutics Inc.’s current trading price is -81.73% away from its 52-week high, while its distance from the 52-week low is 37.65%. The stock’s price range over this period has fluctuated between $1.70 and $12.81. The company, operating within the financial sector, had a trading volume of approximately 2.9 million for the day, which was noticeably higher than the average daily share volume of 1.31 million over the last 3 months.
At present, Cara Therapeutics Inc. (CARA) has a stock price of $2.34. In the previous session, the stock saw a rise, peaking at $2.48 after an opening price of $2.07. The day’s lowest price was $2.06, and it closed at $2.07.
Cara Therapeutics Inc.’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $12.81 on 12/02/22 and a low of $1.70 for the same time frame on 09/13/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cara Therapeutics Inc. (CARA) has experienced a quarterly decline of -27.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 111.90M and boasts a workforce of 106 employees.
Cara Therapeutics Inc.: What Analysts Are Saying
As of right now, 6 analysts are rating Cara Therapeutics Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.18, with a change in price of -1.66. Similarly, Cara Therapeutics Inc. recorded 1,151,745 in trading volume during the last 100 days, posting a change of -41.50%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CARA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CARA Stock Stochastic Average
Today, Cara Therapeutics Inc.’s raw stochastic average for the past 50 days stands at 36.57%, indicating a decline from the raw stochastic average of the last 20 days, which was 47.06%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 27.70% and 14.47% respectively.
CARA Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a loss of -78.21%.However, over the last six months, we can see a stronger performance of -59.52%. Over the last 30 days, the price of CARA has leaped by -20.14%. And in the last five days, it has surged by 21.88%.